Sequent Scientific’s arm forays into European Veterinary Pharmaceutical markets

04 Dec 2015 Evaluate

Sequent Scientific’s subsidiary Alivira Animal Healthcare has forayed into the European Veterinary Pharmaceutical markets through acquisition of three companies - N-Vet AB, Fendigo SA & Fendigo BV. The transactions are in line with Alivira’s stated focus of becoming a leading global and integrated company in the Animal Health space.

Alivira has acquired 85% stake in the aforementioned companies with the current management retaining the balance stake. The structure of the transaction permits the current management team to drive the business while Alivira would provide a stronger framework for growth through a larger product portfolio, backed by regulatory compliance, global reach and integrated manufacturing capabilities.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.


Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×